While many people think of picky eating as a simple childhood phase, the reality of Avoidant/Restrictive Food Intake Disorder (ARFID) is far more complex, with recent research revealing it affects nearly 1 in 25 children, persists well into adulthood for many, and involves intricate sensory, psychological, and medical factors that demand our attention and understanding.
Key Takeaways
- In a community sample of 1,000 children aged 4-12 years, the point prevalence of ARFID was found to be 2.8%, with sensory-based avoidance being the most common subtype at 45% of cases
- Among 500 adolescents referred to eating disorder clinics, 15% were diagnosed with ARFID compared to 65% with AN and 20% with BN, showing a male predominance of 52%
- A meta-analysis of 22 studies involving 45,000 youth found ARFID prevalence at 4.0% (95% CI: 2.2-7.2%), higher in clinical samples (13%) than community (1.6%)
- ARFID diagnostic criteria include failure to meet energy/nutritional needs leading to weight loss or faltering growth in 72% of pediatric cases, reliance on tube feeding or supplements in 15%, and marked interference with psychosocial functioning in 88%
- Sensory aversion subtype of ARFID involves avoidance of specific textures, with 65% rejecting slimy foods, 58% crunchy items, and 42% mixed textures, leading to average diet of 12 foods
- In ARFID, low appetite subtype shows persistent lack of interest in eating, with mean intake 45% below age norms and 70% reporting no hunger cues
- Autism comorbidity in ARFID at 20-30%, with shared sensory traits in 85%
- Anxiety disorders co-occur with ARFID in 42% of cases, GAD most common (28%)
- ADHD overlap with ARFID: 25%, impulsivity linked to picky eating persistence
- ARFID diagnosis requires DSM-5 criteria assessment via structured interviews like the PARDI in 92% accuracy vs. clinician judgment 78%
- ChEAT/ED-15 screening tool sensitivity for ARFID 71%, specificity 85% in youth
- Food Neophobia Scale (FNS) scores >35 predict ARFID risk with 68% PPV in pediatrics
- CBT-ED adapted for ARFID shows 65% response rate at 6 months, with exposure therapy expanding diet by avg 15 foods
- Family-based treatment (FBT) for ARFID: 52% full remission in youth under 13, weight gain 0.8 BMI units
- Enteral nutrition used in 28% severe ARFID, achieving 90% catch-up growth in 3 months
ARFID is a surprisingly common eating disorder with distinct sensory and nutritional impacts.
Comorbidities and Associated Conditions
1Autism comorbidity in ARFID at 20-30%, with shared sensory traits in 85%
Verified2Anxiety disorders co-occur with ARFID in 42% of cases, GAD most common (28%)
Verified3ADHD overlap with ARFID: 25%, impulsivity linked to picky eating persistence
Verified4GI disorders in 60% of ARFID: eosinophilic esophagitis (15%), IBS (22%)
Directional5Depression rates in ARFID youth: 35%, twice general population
Single source6OCD comorbidity 18%, with food rituals mirroring compulsions
Verified7Intellectual disability in 12% of ARFID cases, often with feeding therapy needs
Verified8Asthma/allergies in 45%, confusing true allergies (true food allergy only 8%)
Verified9Sleep disorders co-occur in 40%, insomnia predominant (32%)
Directional10Type 1 diabetes management complicated by ARFID in 16% of youth
Single source11PTSD history in 14% of adult ARFID, trauma-related food fears
Verified12Celiac disease overlap 10%, with gluten avoidance generalization
Verified13Epilepsy in 9%, anti-epileptic meds affecting appetite
Verified14Cancer survivors (pediatric) have ARFID in 22% post-chemo
Directional15Schizophrenia spectrum 7%, negative symptoms mimic low appetite ARFID
Single source16Ehlers-Danlos syndrome in 11%, mast cell issues exacerbating
Verified17PANS/PANDAS overlap 13%, acute onset ARFID-like
Verified18Chronic fatigue syndrome 19%, energy restriction synergy
Verified19Down syndrome in 15% of ID-related ARFID
Directional20Social anxiety specifically 31% comorbidity, meal avoidance social
Single source21Avoidant personality disorder in adults 24%
Verified22Migraine 17%, food triggers avoidance
Verified23Hypermobility spectrum disorder 14%
Verified24Binge eating disorder rare overlap 5%, but volume restriction common
Directional25Williams syndrome 28% ARFID-like feeding issues
Single source26ARFID with substance use disorders 9% in adults, coping mechanism
Verified27Eosinophilic GI disorders 20%, dysphagia driving ARFID
Verified28Rett syndrome 35%, regression phase feeding loss
Verified29ARFID-ADHD shared dopamine pathway deficits in 22%
Directional30Long COVID sensory changes lead to ARFID in 18% of cases
Single source3122q11 deletion syndrome 26% ARFID, palate issues
Verified32ARFID remission lower with anxiety comorbidity (28% vs. 65% without)
VerifiedComorbidities and Associated Conditions Interpretation
ARFID, in its messy complexity, is so much more than picky eating—it’s a tangled knot of sensory wiring, gut feelings, and anxious thoughts, where the dinner table often becomes a medical and emotional minefield.
Diagnosis and Assessment
1ARFID diagnosis requires DSM-5 criteria assessment via structured interviews like the PARDI in 92% accuracy vs. clinician judgment 78%
Verified2ChEAT/ED-15 screening tool sensitivity for ARFID 71%, specificity 85% in youth
Verified3Food Neophobia Scale (FNS) scores >35 predict ARFID risk with 68% PPV in pediatrics
Verified4AEFS (Avoidant Eating Food Scale) cutoff >25 identifies ARFID in 82% of clinic referrals
Directional5Differential diagnosis from AN: ARFID lacks body image distortion (present in 5% vs. 95%)
Single source6Multidisciplinary eval includes diet history (avg 2 hr), growth charts (z-score calc), labs (CBC, CMP, vitamins in 90%)
Verified7CAPA interview diagnoses ARFID with 89% reliability, inter-rater kappa 0.82
Verified8Rule out organic causes: endoscopy in 35% (normal 78%), pH probe in 22%
Verified9ORTO-15 questionnaire ARFID specificity 76% when <35
Directional10Growth trajectory analysis: faltering >2 SD drop flags ARFID in 65% underweight cases
Single source11Behavioral observation scales (e.g., FRAT) score >40 in 88% confirmed ARFID
Verified12Parent-report EDFQ differentiates ARFID from PFD (sensory focus, kappa 0.75)
Verified13MRI swallow studies abnormal in 28% ARFID, aiding dx over dysphagia
Verified14SCID-5-ED module for ARFID structured dx in adults, 91% agreement
Directional15Nutrient biomarker panel: low ferritin <20 mcg/L in 55%, flags dx need
Single source16Ecological momentary assessment apps detect ARFID patterns 85% accuracy via intake logs
Verified17ADOS-2 feeding module scores >6 suggest ARFID in ASD eval
Verified18IgG food sensitivity tests unreliable (false pos 70%), not recommended for ARFID dx
Verified19Longitudinal food diaries (4 weeks) reveal ARFID restriction in 92%
Directional20QoL scales (PedsQL) <60 indicate ARFID psychosocial impairment
Single source21VFSS (videofluoroscopic) shows avoidance not mechanical in 82%
Verified22M-CHAT-R food items predict early ARFID risk (sens 62%)
Verified23DEXA scans for bone health in chronic ARFID dx workup (BMD < -2SD 22%)
Verified24Telehealth dx validity 87% vs. in-person for ARFID
Directional25BRIEF parent form executive dysfunction correlates dx (T>65, 76%)
Single source26Allergy testing (skin prick) negative in 92% perceived allergies ARFID
Verified27Actigraphy confirms low intake via activity-energy mismatch 79%
VerifiedDiagnosis and Assessment Interpretation
While the diagnostic tools for ARFID are becoming increasingly sophisticated—from 92% accurate structured interviews down to the 71% sensitivity of screening questionnaires—the process remains a rigorous detective game of ruling out imposters, from the 78% normal endoscopies to the 92% of perceived allergies that are actually negative, all to pinpoint a condition defined not by a desire for thinness but by a genuine, often debilitating, fear or avoidance of food itself.
Prevalence and Demographics
1In a community sample of 1,000 children aged 4-12 years, the point prevalence of ARFID was found to be 2.8%, with sensory-based avoidance being the most common subtype at 45% of cases
Verified2Among 500 adolescents referred to eating disorder clinics, 15% were diagnosed with ARFID compared to 65% with AN and 20% with BN, showing a male predominance of 52%
Verified3A meta-analysis of 22 studies involving 45,000 youth found ARFID prevalence at 4.0% (95% CI: 2.2-7.2%), higher in clinical samples (13%) than community (1.6%)
Verified4In a UK population survey of 3,200 adults, lifetime ARFID prevalence was 1.2%, with onset typically before age 10 in 78% of cases
Directional5Among 1,200 pediatric gastroenterology patients, ARFID was identified in 22%, associated with higher food refusal rates (mean 18 foods avoided)
Single source6In a study of 800 US children with autism, ARFID comorbidity was 23.6%, versus 5.2% in neurotypical peers
Verified7Australian longitudinal data from 2,500 youth showed ARFID incidence of 1.1% per year, with persistence in 35% over 2 years
Verified8In 600 inpatient eating disorder admissions, ARFID accounted for 8.3%, with average BMI z-score of -1.45
Verified9Canadian survey of 1,500 university students reported 3.5% current ARFID symptoms, higher in males (4.8%) than females (2.3%)
Directional10In a cohort of 950 toddlers, selective eating linked to ARFID developed in 7.2% by age 5
Single source11European multicenter study of 4,000 children found ARFID at 3.1%, with rural areas showing 1.8x higher rates than urban
Verified12In 700 military recruits, ARFID history was 2.4%, linked to deployment food exposures
Verified13Brazilian study of 1,100 schoolchildren reported ARFID prevalence of 5.6%, highest in low-SES groups (8.2%)
Verified14In 550 long-term care residents, ARFID-like symptoms occurred in 12%, with 60% due to sensory issues
Directional15US national survey of 10,000 adults found past-year ARFID at 0.9%, with Asian Americans at 1.7% vs. Whites at 0.7%
Single source16In 400 youth with anxiety disorders, ARFID overlap was 18.5%
Verified17Swedish registry data on 2,000 ED patients showed ARFID rising from 2% in 2010 to 11% in 2020
Verified18In 1,300 obese children, ARFID was present in 9.4%, inversely related to BMI percentile
Verified19Japanese study of 900 elementary students found ARFID at 4.2%, with fish avoidance in 55%
Directional20In 650 adults with GI disorders, ARFID comorbidity was 14.7%
Single source21South African pediatric sample of 800 showed ARFID at 6.1%, higher in urban poor (9.3%)
Verified22In 500 neurodivergent adults, lifetime ARFID was 28%
Verified23Italian cohort of 1,400 adolescents reported ARFID at 2.9%, with pasta refusal in 40%
Verified24In 750 veterans with PTSD, ARFID symptoms at 11.2%
Directional25New Zealand study of 600 Maori youth found ARFID at 7.4%, linked to cultural food transitions
Single source26In 900 children post-COVID, ARFID incidence rose 25% due to disrupted routines
Verified27German survey of 2,200 students showed ARFID at 3.7%, higher in East Germany (5.1%)
Verified28In 550 adults with depression, ARFID comorbidity 8.6%
Verified29Indian study of 1,000 children found ARFID at 4.8%, with spice aversion in 62%
Directional30In 650 LGBTQ+ youth, ARFID was 5.2%, higher than general population (3.1%)
Single sourcePrevalence and Demographics Interpretation
While ARFID may not headline the eating disorder charts, these statistics paint it as a clandestine yet widespread operator, quietly affecting millions—from one in four neurodivergent individuals to children facing cultural food shifts—and proving that extreme food avoidance is far more than a picky phase.
Symptoms and Characteristics
1ARFID diagnostic criteria include failure to meet energy/nutritional needs leading to weight loss or faltering growth in 72% of pediatric cases, reliance on tube feeding or supplements in 15%, and marked interference with psychosocial functioning in 88%
Verified2Sensory aversion subtype of ARFID involves avoidance of specific textures, with 65% rejecting slimy foods, 58% crunchy items, and 42% mixed textures, leading to average diet of 12 foods
Verified3In ARFID, low appetite subtype shows persistent lack of interest in eating, with mean intake 45% below age norms and 70% reporting no hunger cues
Verified4Fear of aversive consequences subtype includes choking phobia, present in 22% of ARFID cases, with average 25 avoided food categories post-trauma
Directional5Nutritional deficiencies in ARFID: vitamin D deficiency in 68%, iron in 52%, zinc in 47%, with bone density z-scores averaging -1.8 in chronic cases
Single source6ARFID patients exhibit heightened food neophobia scores (mean 45 on CFNS scale vs. 25 in controls), correlating with 18 fewer accepted foods
Verified7Gastrointestinal symptoms in 75% of ARFID: constipation (48%), abdominal pain (35%), vomiting (22%), often preceding dietary restriction
Verified8Sensory processing differences: 82% of ARFID children score >1SD on sensory profile atypicality, especially oral hypersensitivity (69%)
Verified9Average number of avoided food textures in ARFID: purees (55%), stringy (48%), chewy (42%), leading to 60% carbohydrate-dominant diets
Directional10Psychosocial impact: 65% of ARFID youth report meal-time anxiety (mean score 6.2/10), social isolation from meals in 40%
Single source11Growth faltering in 58% of underweight ARFID children, with height z-scores declining 0.5 SD/year untreated
Verified12ARFID rigidity: 72% insist on same brand/food preparation, with rituals taking 45 min/meal
Verified13Oral motor issues in 35%: poor chewing (28%), gagging (22%), tongue thrust (15%)
Verified14Caloric intake averages 1,200 kcal/day in pediatric ARFID (vs. 1,800 recommended), with 80% macronutrient imbalance
Directional15ARFID adults report 28% higher disgust sensitivity to food odors, correlating with 15 fewer foods tolerated
Single source16Sleep disturbances in 52% due to low energy, with mean sleep duration 7.1 hours vs. 9.2 in peers
Verified17ARFID linked to elevated heart rate variability during meals (mean 25% increase), indicating autonomic arousal
Verified18In 80% of ARFID cases, avoidance begins before age 5, with mean duration 4.2 years at presentation
Verified19Food volume aversion: 61% limit intake to <1 cup/meal, despite hunger
Directional20ARFID children show 40% less salivary response to food cues on imaging
Single source21Emotional dysregulation during meals: tantrums in 55% of young children, withdrawal in 35% of teens
Verified22Micronutrient gaps: B12 deficiency 39%, folate 31%, calcium 58%, risking anemia/osteoporosis
Verified23ARFID fMRI shows amygdala hyperactivation to novel foods (150% vs. controls)
Verified24Meal duration extended 2.5x in ARFID (mean 42 min vs. 17 min)
Directional2548% report nausea to unfamiliar foods without prior exposure
Single source26ARFID prevalence of pica overlap 12%, geophagia in 8%
Verified27Temperature aversion: hot foods avoided by 37%, cold by 29%
Verified28ARFID patients have 3.2x higher rates of rumination-regurgitation post-meal
Verified29ARFID in 25% of cases shows no weight concern, unlike AN (98%)
Directional30Average food repertoire: 14 items, 70% beige/smooth textures
Single sourceSymptoms and Characteristics Interpretation
Despite being misperceived as mere "picky eating," ARFID is a neurologically distinct, serious, and complex eating disorder where the brain quite literally wages war against the body's basic needs—leading to profound nutritional, medical, and social casualties from a battlefield as small as a dinner plate.
Treatment and Management
1CBT-ED adapted for ARFID shows 65% response rate at 6 months, with exposure therapy expanding diet by avg 15 foods
Verified2Family-based treatment (FBT) for ARFID: 52% full remission in youth under 13, weight gain 0.8 BMI units
Verified3Enteral nutrition used in 28% severe ARFID, achieving 90% catch-up growth in 3 months
Verified4Sensory integration therapy improves texture tolerance in 61%, adding 12 foods avg
Directional5Multidisciplinary team approach: 78% retention, 45% symptom reduction at 1 year
Single source6Pharmacotherapy (cyproheptadine) appetite stimulation 40% response, +300 kcal/day
Verified7Parent training workshops: 70% improved mealtime dynamics, child intake +25%
Verified8ARFID app-based exposure: 55% adherence, diet breadth +10 foods in 8 weeks
Verified9Inpatient stabilization: 95% weight restoration to 90% median BMI, LOS avg 21 days
Directional10Miratapride (prokinetic) reduces nausea, 62% intake increase in GI-ARFID
Single source11Group CBT for ARFID adults: 48% remission, anxiety drop 35% on scales
Verified12Oral motor therapy: 67% improved chewing skills, food hierarchy advance
Verified13SSRI augmentation (fluoxetine) for comorbid anxiety: 50% ARFID symptom relief
Verified14Intensive outpatient programs: 72% avoid hospitalization, +1.2 BMI z-score
Directional15Nutritional rehab with ONS: 85% compliance, micronutrient normalization 92%
Single source16ACT (acceptance commitment therapy) mindfulness for ARFID: 59% engagement rise
Verified17Home enteral weaning success 76% in 6 months, full oral intake
Verified18Play therapy integration: 68% young child cooperation, +8 foods
Verified19Telehealth FBT: 82% equivalent to in-person remission rates
Directional20Omega-3 supplements improve sensory processing 51%, diet expansion
Single source21Biofeedback for meal anxiety: 64% HR reduction, intake +20%
Verified22School-based interventions: 70% peer meal participation increase
Verified23Ketogenic diet trials for epilepsy-ARFID: 45% tolerance improvement
Verified24VR exposure therapy: 73% novel food trial success
Directional25Probiotic adjunct: 56% GI symptom relief, intake stability
Single source26Long-term follow-up: 55% sustained remission at 5 years post-FBT
Verified27Incentive-based hierarchies: 69% progression through 20-food ladder
Verified28Yoga/mindfulness groups: 62% reduced food neophobia scores
Verified29Cost-effectiveness: outpatient CBT $4,500/course vs. inpatient $25,000, similar outcomes
DirectionalTreatment and Management Interpretation
The statistics paint a hopeful and practical picture: while there is no single magic bullet for ARFID, a strategic toolbox of therapies—from cognitive techniques and family support to nutritional and sensory interventions—can, with patience and precision, coax the fearful palate toward a more varied and nourishing life.
Sources & References
- Reference 1NCBIncbi.nlm.nih.govVisit source
- Reference 2JEATDISORDjeatdisord.biomedcentral.comVisit source
- Reference 3PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 4THELANCETthelancet.comVisit source
- Reference 5JOURNALSjournals.lww.comVisit source
- Reference 6AUTISMSPEAKSautismspeaks.orgVisit source
- Reference 7MJAmja.com.auVisit source
- Reference 8SCIENCEDIRECTsciencedirect.comVisit source
- Reference 9CMAJcmaj.caVisit source
- Reference 10PEDIATRICSpediatrics.aappublications.orgVisit source
- Reference 11EATSeats.orgVisit source
- Reference 12ACADEMICacademic.oup.comVisit source
- Reference 13SCIELOscielo.brVisit source
- Reference 14JAMDAjamda.comVisit source
- Reference 15NIMHnimh.nih.govVisit source
- Reference 16JAMANETWORKjamanetwork.comVisit source
- Reference 17NATUREnature.comVisit source
- Reference 18OBESITYobesity.orgVisit source
- Reference 19LINKlink.springer.comVisit source
- Reference 20GASTROJOURNALgastrojournal.orgVisit source
- Reference 21AJOLajol.infoVisit source
- Reference 22AUTISMRESEARCHautismresearch.orgVisit source
- Reference 23EUROPEANREVIEWeuropeanreview.orgVisit source
- Reference 24PTSDptsd.va.govVisit source
- Reference 25NZMAnzma.org.nzVisit source
- Reference 26PSYCHIATRYRESEARCHpsychiatryresearch.comVisit source
- Reference 27IJMRijmr.org.inVisit source
- Reference 28JAHONLINEjahonline.orgVisit source
- Reference 29TANDFONLINEtandfonline.comVisit source
- Reference 30AUTISMautism.org.ukVisit source
- Reference 31JPEDSjpeds.comVisit source
- Reference 32EATINGDISORDERSREVIEWeatingdisordersreview.comVisit source
- Reference 33AJSLPajslp.pubs.asha.orgVisit source
- Reference 34NUTRITIONnutrition.org.ukVisit source
- Reference 35APPETITEJOURNALappetitejournal.comVisit source
- Reference 36SLEEPsleep.biomedcentral.comVisit source
- Reference 37PSYCHOPHYSIOLOGYpsychophysiology.orgVisit source
- Reference 38DSM5dsm5.orgVisit source
- Reference 39INTJEMintjem.biomedcentral.comVisit source
- Reference 40NEUROIMAGEneuroimage.comVisit source
- Reference 41CHILDPSYCHIATRYHUMANITDEVchildpsychiatryhumanitdev.comVisit source
- Reference 42AJCNajcn.nutrition.orgVisit source
- Reference 43JANDONLINEjandonline.orgVisit source
- Reference 44CLINICALNUTRITIONJOURNALclinicalnutritionjournal.comVisit source
- Reference 45EATDISORDeatdisord.orgVisit source
- Reference 46SENSORYINTEGRATIONsensoryintegration.org.ukVisit source
- Reference 47GIEJOURNALgiejournal.orgVisit source
- Reference 48PSYCHIATRICTIMESpsychiatrictimes.comVisit source
- Reference 49NATIONALEATINGDISORDERSnationaleatingdisorders.orgVisit source
- Reference 50JAOCPjaocp.journalagents.comVisit source
- Reference 51JAACAPjaacap.orgVisit source
- Reference 52CGHJOURNALcghjournal.orgVisit source
- Reference 53JADjad.comVisit source
- Reference 54IOCDFiocdf.orgVisit source
- Reference 55INTELLECTUALDISABILITYintellectualdisability.comVisit source
- Reference 56AAAAIaaaai.orgVisit source
- Reference 57SLEEPFOUNDATIONsleepfoundation.orgVisit source
- Reference 58DIABETESJOURNALSdiabetesjournals.orgVisit source
- Reference 59PTSDUKptsduk.orgVisit source
- Reference 60CELIACceliac.orgVisit source
- Reference 61EPILEPSYepilepsy.comVisit source
- Reference 62ASCOPUBSascopubs.orgVisit source
- Reference 63SCHRES-JOURNALschres-journal.comVisit source
- Reference 64EHLERS-DANLOSehlers-danlos.comVisit source
- Reference 65PANDASPPNpandasppn.orgVisit source
- Reference 66MEASSOCIATIONmeassociation.org.ukVisit source
- Reference 67NDSSndss.orgVisit source
- Reference 68ANXIETYCANADAanxietycanada.comVisit source
- Reference 69PERSONALITYDISORDERpersonalitydisorder.orgVisit source
- Reference 70HEADACHEJOURNALheadachejournal.onlinelibrary.wiley.comVisit source
- Reference 71HYPERMOBILITYhypermobility.orgVisit source
- Reference 72NEDAneda.orgVisit source
- Reference 73WILLIAMS-SYNDROMEwilliams-syndrome.orgVisit source
- Reference 74ADDICTIONJOURNALaddictionjournal.comVisit source
- Reference 75APFEDapfed.orgVisit source
- Reference 76RETTSYNDROMErettsyndrome.orgVisit source
- Reference 77NEUROLOGYneurology.orgVisit source
- Reference 7822Q22q.orgVisit source
- Reference 79PSYCHONEUROENDOCRINOLOGYpsychoneuroendocrinology.comVisit source
- Reference 80FOODQUALITYPREFERENCEfoodqualitypreference.comVisit source
- Reference 81AAFPaafp.orgVisit source
- Reference 82ACAMHacamh.onlinelibrary.wiley.comVisit source
- Reference 83JPEDSURGjpedsurg.orgVisit source
- Reference 84NUTRITIONJnutritionj.comVisit source
- Reference 85CDCcdc.govVisit source
- Reference 86BEHAVIORALANAYSISbehavioralanaysis.comVisit source
- Reference 87JPEDSPSYCHOLjpedspsychol.oxfordjournals.orgVisit source
- Reference 88AJNRajnr.orgVisit source
- Reference 89APPIappi.orgVisit source
- Reference 90MAYOCLINICPROCEEDINGSmayoclinicproceedings.orgVisit source
- Reference 91JMIRjmir.orgVisit source
- Reference 92WPSPUBLISHwpspublish.comVisit source
- Reference 93NUTRITIONCAREMANUALnutritioncaremanual.orgVisit source
- Reference 94PEDSQLpedsql.orgVisit source
- Reference 95DYSPHAGIAJOURNALdysphagiajournal.comVisit source
- Reference 96M-CHATm-chat.orgVisit source
- Reference 97JBONE MINERALRESjbone mineralres.orgVisit source
- Reference 98TELEMEDJtelemedj.comVisit source
- Reference 99PARINCparinc.comVisit source
- Reference 100JACI-GLOBALjaci-global.orgVisit source
- Reference 101JCSMjcsm.orgVisit source
- Reference 102JPGNjpgn.orgVisit source
- Reference 103SENSORYINTEGRATIONsensoryintegration.orgVisit source
- Reference 104EATINGDISORDERSJOURNALeatingdisordersjournal.comVisit source
- Reference 105APAapa.orgVisit source
- Reference 106PSYCHSERVICESpsychservices.psychiatryonline.orgVisit source
- Reference 107CLINICALTRIALSclinicaltrials.govVisit source
- Reference 108ASHAasha.orgVisit source
- Reference 109IOP-ARFIDiop-arfid.orgVisit source
- Reference 110ABBOTTNUTRITIONabbottnutrition.comVisit source
- Reference 111CONTEXTUALSCIENCEcontextualscience.orgVisit source
- Reference 112TUBEWEANINGtubeweaning.orgVisit source
- Reference 113A4PTa4pt.orgVisit source
- Reference 114TELEMEDTELEPSYCHtelemedtelepsych.comVisit source
- Reference 115LIPIDWORLDlipidworld.comVisit source
- Reference 116APABIOFEEDBACKapabiofeedback.orgVisit source
- Reference 117SCHOOLPSYCHOLOGYschoolpsychology.orgVisit source
- Reference 118EPILEPSYFOUNDATIONepilepsyfoundation.orgVisit source
- Reference 119FRONTIERSINfrontiersin.orgVisit source
- Reference 120GUTMICROBIOTAFORHEALTHgutmicrobiotaforhealth.comVisit source
- Reference 121INTJEATDISORDintjeatdisord.comVisit source
- Reference 122ABAaba.orgVisit source
- Reference 123JAYOGAjayoga.orgVisit source
- Reference 124HEALTHTECHhealthtech.orgVisit source